Source:http://linkedlifedata.com/resource/pubmed/id/16775487
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0009319,
umls-concept:C0021853,
umls-concept:C0039194,
umls-concept:C0181586,
umls-concept:C0205191,
umls-concept:C0205307,
umls-concept:C0333668,
umls-concept:C0337051,
umls-concept:C1292733,
umls-concept:C1332714,
umls-concept:C1334114,
umls-concept:C1509144,
umls-concept:C1512658,
umls-concept:C1704410
|
pubmed:issue |
6
|
pubmed:dateCreated |
2006-6-15
|
pubmed:abstractText |
BACKGROUND: CD4+CD25+ regulatory T cells have been shown to prevent immune-mediated colitis in mice; however, it is unclear whether the absence of CD4+CD25+ in the normal CD4+ T cell pool is responsible for the development of chronic colitis. Using the T cell-deficient Tgepsilon26 mouse model, we show that CD4+CD25- cells but not CD4+CD25+ cells induce a severe intestinal inflammation. Transfer of CD4+CD25+ cells, together with CD4+CD25- cells, ameliorated intestinal inflammation, and reconstitution with the whole mesenteric lymph node cell pool did not induce colitis in recipients. Transferred CD4+CD25- cells were found mainly in the mesenteric lymph nodes, where they showed an activated TH1-like phenotype. In the absence of regulatory CD4+CD25+ T cells, recipient CD4 cells secreted IFN-gamma in response to stimulation with intestinal bacterial antigen that was prevented in vivo and in vitro by regulatory CD4+CD25+ cells. These studies suggest that CD4+CD25- cells have a strong colitogenic effect in the Tgepsilon26 colitis model and that CD4+CD25+ cells may be the main regulators that prevent or downregulate the proinflammatory effect of colitogenic T cells in the Tgepsilon26 mouse model.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1078-0998
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
437-46
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16775487-Animals,
pubmed-meshheading:16775487-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16775487-Chronic Disease,
pubmed-meshheading:16775487-Colitis,
pubmed-meshheading:16775487-Disease Models, Animal,
pubmed-meshheading:16775487-Immune Tolerance,
pubmed-meshheading:16775487-Immunocompromised Host,
pubmed-meshheading:16775487-Intestines,
pubmed-meshheading:16775487-Lymph Nodes,
pubmed-meshheading:16775487-Lymphocyte Depletion,
pubmed-meshheading:16775487-Mesentery,
pubmed-meshheading:16775487-Mice,
pubmed-meshheading:16775487-Receptors, Interleukin-2,
pubmed-meshheading:16775487-Spleen,
pubmed-meshheading:16775487-T-Lymphocyte Subsets
|
pubmed:year |
2006
|
pubmed:articleTitle |
CD4+CD25+ cell depletion from the normal CD4+ T cell pool prevents tolerance toward the intestinal flora and leads to chronic colitis in immunodeficient mice.
|
pubmed:affiliation |
Department of Gastroenterology, Ruprecht-Karls-University, Heidelberg, Germany. Claudia_veltkamp@med.uni-heidelberg.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|